期刊文献+

芳香化酶抑制剂(来曲唑)可有效治疗男性部分性特发性低促性腺激素性性腺功能减退症 被引量:6

Aromatase inhibitor(letrozole) is effective in activating the function of hypothalamus-pituitary-gonad axis in male patients with partial idiopathic hypogonadotropic hypogonadism
原文传递
导出
摘要 应用来曲唑治疗3个月的男性部分性特发性低促性腺激素性性腺功能减退症(idiopathic hypogonadotropic hypogonadism,IHH)患者18例。治疗3个月后LH[(3.6±3.7对2.1±1.5) IU/L,P=0.029]和FSH[(4.3±3.4对2.6±1.8) IU/L,P=0.003]均较治疗前明显升高。总睾酮从治疗前(87±42) ng/dl升高至(166±200) ng/dl(P=0.082)。雌二醇从(22.7±18.7) pg/ml降至(13.4±10.6) pg/ml(P=0.020)。治疗前后睾丸体积(两侧睾丸体积平均值)分别是(11.2±4.9)和(14.3±3.9) ml(P<0.01)。在完善精液常规的9例患者中,有8例治疗后精液中可检测到精子。线性模型分析的结果显示,促性腺激素释放激素类似物(曲普瑞林)兴奋试验中LH(60 min)水平较高者,药物治疗后总睾酮水平更容易升高( P=0.045)。 [Summary] Eighteen patients with idiopathic hypogonadotropic hypogonadism( IHH) receiving aromatase-inhibitor( AI) letrozole for at least 3 months were recruited.After 3 months′treatment, LH levels were increased from (2.1 ±1.5) IU/L to (3.6 ±3.7) IU/L(P=0.029), and FSH levels from (2.6±1.8) IU/L to (4.3 ±3.4) IU/L (P=0.003).Total testosterol was increased from (87 ±42) ng/dl to (166 ±200) ng/dl(P=0.082), and estradiol wasdecreasedfrom(22.7±18.7) pg/ml to (13.4±10.6) pg/ml(P=0.020).The average testis volume was increased[(14.3 ±3.9 vs 11.2 ±4.9) ml, P<0.01].Sperms were detected in 8 out of 9 patients who did seminal fluid test.The result of general linear model showed that LH(60 min) was significantly related with total testosterol increment( P=0.045) .
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2016年第2期125-127,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 芳香化酶抑制剂 特发性低促性腺激素性性腺功能减退症 治疗 Aromatase inhibitor Idiopathic hypogonadotropic hypogonadism Treatment
  • 相关文献

参考文献16

  • 1Corona G, Rastrelli G, Vignozzi L, et al. Emerging medication for thetreatment of male hypogonadism [ J ]. Expert Opin Emerg Drugs, 20 l 2, 17(2) :239-259.
  • 2Hayes FJ, Seminara SB, Decruz S, et al. Aro~natase inhibition in the human male reveals a hypothalamic site of estrogen feedback [ J 1. J Clin Endocrinol Metab, 2000,85 ( 9 ) :3027-3035.
  • 3Pitteloud N, Dwyer AA, Decruz S, et al. Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men [ J ]. J Clin Endocrinol Metab, 2008,93 (3) :784-791.
  • 4Holbrook JM, Cohen PG. Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation [ J ]. South Med J, 2003,96 ( 6 ) : 544-547.
  • 5伍学焱,聂敏,卢双玉,茅江峰.曲普瑞林兴奋试验在评价男性下丘脑-垂体-性腺轴功能中的价值[J].中华医学杂志,2011,91(10):679-682. 被引量:15
  • 6Bouvattier C, Maione L, Bouligand J, et al. Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism [J]. Nat Rev Endocrinol, 2012,8(3 ) : 172-182.
  • 7Hadziselimovic NO, de Geyter C, Demougin P, et al. Decreased expression of FGFRI, SOS1. RAF1 genes in cryptorchidism[J]. Urol Int, 2010,84(3 ) :353-36l.
  • 8Cotton L, Gibbs GM, Sanchez-Partida LG, et al. FGFR-I [ corrected] signaling is involved in spermiogenesis and sperm capacitation [ J ]. J Cell Sci, 2006,119( 1 ) :75-84.
  • 9Nishio H, Mizuno K, Moritoki Y, et al. Clinical features and testicular morphology in patients with Kallmann syndrome [ J ]. Urology, 2012,79 (3) :684-686.
  • 10Salenave S, Chanson P, Bry H, et al. Kalhnann' s syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations [ J ]. J Clin Endocrinol Metab, 2008,93 ( 3 ) : 758-763.

二级参考文献9

共引文献14

同被引文献41

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部